Characterization data includes
We have characterized additional genomic and cell surface makers and work with clients in determining the expression of their drug target. Please contact us to learn more.
Assays conducted to date
- Comparative studies using Keytruda (anti-PD-1) and Tecentriq (anti-PD-L1) candidates to measure tumor lysis)
- Comparative studies using Yervoy (anti-CTLA4)
- Effect of drug candidate(s) on CTL 007 migration in 3D co-culture with WC 007
- Immunosuppressive studies using allogeneic Tregs and Macrophages on CTL 007 inhibition of WC 007 lysis